Jeffrey S Berns

Summary

Affiliation: University of Pennsylvania
Country: USA

Publications

  1. ncbi request reprint That catheter is going to cost you!
    Jeffrey S Berns
    Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 19:440-2. 2006
  2. ncbi request reprint Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists
    Jeffrey S Berns
    Renal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania School of Medicine, Penn Presbyterian Medical Center, 51 N 39th Street, Medical Office Building 240, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 1:117-29. 2006
  3. ncbi request reprint Viruses and diseases of the kidneys
    Jeffrey S Berns
    The Renal Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin J Am Soc Nephrol 2:S1. 2007
  4. pmc Performance of procedures by nephrologists and nephrology fellows at U.S. nephrology training programs
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, 1 Founders Pavilion, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 3:941-7. 2008
  5. pmc A survey-based evaluation of self-perceived competency after nephrology fellowship training
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, 1 Founders Pavilion, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 5:490-6. 2010
  6. ncbi request reprint The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19146, USA
    Hemodial Int 9:255-63. 2005
  7. ncbi request reprint Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis
    Jeffrey S Berns
    Department of Medicine Renal Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Presbyterian Medical Center, 51 N 39th Street, Medical Office Building No 240, Philadelphia, PA 19104, U S A
    Hemodial Int 9:7-22. 2005
  8. doi request reprint Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Curr Opin Nephrol Hypertens 19:567-72. 2010
  9. ncbi request reprint Should the target hemoglobin for patients with chronic kidney disease treated with erythropoietic replacement therapy be changed?
    Jeffrey S Berns
    Department of Medicine, Renal, Electrolyte, Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 191041, USA
    Semin Dial 18:22-9. 2005
  10. ncbi request reprint Infection with antimicrobial-resistant microorganisms in dialysis patients
    Jeffrey S Berns
    Department of Medicine, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania School of Medicine and Presbyterian Medical Center, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 16:30-7. 2003

Collaborators

Detail Information

Publications53

  1. ncbi request reprint That catheter is going to cost you!
    Jeffrey S Berns
    Renal Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 19:440-2. 2006
  2. ncbi request reprint Highly active antiretroviral therapy and the kidney: an update on antiretroviral medications for nephrologists
    Jeffrey S Berns
    Renal, Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania School of Medicine, Penn Presbyterian Medical Center, 51 N 39th Street, Medical Office Building 240, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 1:117-29. 2006
    ....
  3. ncbi request reprint Viruses and diseases of the kidneys
    Jeffrey S Berns
    The Renal Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA
    Clin J Am Soc Nephrol 2:S1. 2007
  4. pmc Performance of procedures by nephrologists and nephrology fellows at U.S. nephrology training programs
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, 1 Founders Pavilion, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 3:941-7. 2008
    ..To assess the procedures performed by nephrologists and nephrology fellows at U.S. adult nephrology training programs and the number of procedures required for fellow competency, a survey was conducted of all such training programs...
  5. pmc A survey-based evaluation of self-perceived competency after nephrology fellowship training
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, 1 Founders Pavilion, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 5:490-6. 2010
    ..There have been no recent analyses of the adequacy of training in U.S. nephrology training programs or the importance of specific aspects of fellowship training in the careers and practices of nephrologists who recently completed training...
  6. ncbi request reprint The effect of a change in epoetin alfa reimbursement policy on anemia outcomes in hemodialysis patients
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19146, USA
    Hemodial Int 9:255-63. 2005
    ..The decline in mean weekly dose of epoetin was likely a result of withholding doses out of concern among providers about risk of reimbursement denial...
  7. ncbi request reprint Pharmacologic adjuvants to epoetin in the treatment of anemia in patients on hemodialysis
    Jeffrey S Berns
    Department of Medicine Renal Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Presbyterian Medical Center, 51 N 39th Street, Medical Office Building No 240, Philadelphia, PA 19104, U S A
    Hemodial Int 9:7-22. 2005
    ..A review of published guidelines and recommendations for use of these agents in hemodialysis patients is provided...
  8. doi request reprint Are there implications from the Trial to Reduce Cardiovascular Events with Aranesp Therapy study for anemia management in dialysis patients?
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Curr Opin Nephrol Hypertens 19:567-72. 2010
    ..This review addresses this and other recent studies of ESA treatment for renal anemia to higher hemoglobin (Hgb) targets above the range of 10-12 g/dl...
  9. ncbi request reprint Should the target hemoglobin for patients with chronic kidney disease treated with erythropoietic replacement therapy be changed?
    Jeffrey S Berns
    Department of Medicine, Renal, Electrolyte, Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 191041, USA
    Semin Dial 18:22-9. 2005
    ..Future efforts are likely to focus on selecting patient populations most likely to benefit from normalizing Hb, while adjusting the range of a subnormal Hb target for others...
  10. ncbi request reprint Infection with antimicrobial-resistant microorganisms in dialysis patients
    Jeffrey S Berns
    Department of Medicine, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania School of Medicine and Presbyterian Medical Center, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 16:30-7. 2003
    ..Preventing transmission of antimicrobial-resistant microorganisms in health care settings, including outpatient dialysis facilities, is important in limiting the spread of these resistant organisms...
  11. ncbi request reprint Preventing bacterial infections and antimicrobial resistance in dialysis patients
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Presbyterian Medical Center, Philadelphia, PA 19104, USA
    Am J Kidney Dis 40:886-98. 2002
    ..Fourth, preventing transmission in health care settings is important to limit the spread of resistant organisms. In this regard, such basic measures as glove use and hand hygiene are most important...
  12. ncbi request reprint Hemoglobin variability in epoetin-treated hemodialysis patients
    Jeffrey S Berns
    Renal, Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Kidney Int 64:1514-21. 2003
    ..This study examines hemoglobin variability under conditions of standard clinical practice in epoetin-treated hemodialysis patients...
  13. pmc History-adjusted marginal structural analysis of the association between hemoglobin variability and mortality among chronic hemodialysis patients
    Steven M Brunelli
    Renal, Electrolyte and Hypertension Division of the Department of Medicine, Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Clin J Am Soc Nephrol 3:777-82. 2008
    ..The causal nature of this association has been difficult to ascertain because of potential time-dependent confounding, for which traditional statistical methods do not control...
  14. doi request reprint Staphylococcus-infected tunneled dialysis catheters: is over-the-wire exchange an appropriate management option?
    Jessica M Langer
    Division of Interventional Radiology, Department of Radiology, University of Pennsylvania Medical Center, Philadelphia, PA 19104, USA
    Cardiovasc Intervent Radiol 34:1230-5. 2011
    ..This study addressed the effectiveness of over-the-wire exchange of staphylococcus-infected tunneled dialysis catheters compared with non-staphylococcus-infected tunneled dialysis catheters...
  15. ncbi request reprint Anemia and mortality in hemodialysis patients: accounting for morbidity and treatment variables updated over time
    Bruce M Robinson
    Center for Clinical Epidemiology and Biostatistics, University of Pennsylvania School of Medicine, Philadelphia, 19104, USA
    Kidney Int 68:2323-30. 2005
    ....
  16. pmc Creatinine generation is reduced in patients requiring continuous venovenous hemodialysis and independently predicts mortality
    Francis P Wilson
    Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
    Nephrol Dial Transplant 27:4088-94. 2012
    ..Failure to appreciate variation in CGR may lead to erroneous conclusions regarding severity of AKI and distorted predictions regarding patient outcomes based on AKI severity...
  17. ncbi request reprint Handoff communication between hospital and outpatient dialysis units at patient discharge: a qualitative study
    James B Reilly
    Renal Electrolyte and Hypertension Division, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, USA
    Jt Comm J Qual Patient Saf 39:70-6. 2013
    ..Little is known about how dialysis-specific information is shared with outpatient dialysis clinics for discharged patients, and the applicability of existing models of handoff transitions is unknown...
  18. pmc Red blood cell transfusion risks in patients with end-stage renal disease
    Yvette C Tanhehco
    Division of Laboratory Medicine, Department of Pathology, Perelman School of Medicine at University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Semin Dial 25:539-44. 2012
    ..This article reviews the modern day infectious and noninfectious risks of allogeneic RBC transfusions...
  19. doi request reprint Effect of darbepoetin alfa on endothelial progenitor cells and vascular reactivity in chronic kidney disease
    Emile R Mohler
    Department of Medicine, Cardiovascular Division, Vascular Medicine Section, University of Pennsylvania School of Medicine, PA, USA
    Vasc Med 16:183-9. 2011
    ....
  20. ncbi request reprint Use of low molecular weight heparins and glycoprotein IIb/IIIa inhibitors in patients with chronic kidney disease
    Ari Mosenkis
    Renal, Electrolyte, and Hypertension Division, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 17:411-5. 2004
    ..This article examines the available literature regarding the pharmacokinetics, dosing, efficacy, and safety of LMWH and Gp IIb/IIIa inhibitors in patients with CKD...
  21. ncbi request reprint The safety of heparins in end-stage renal disease
    Samsher Sonawane
    Department of Medicine, Renal, Electrolyte, and Hypertension Division, Penn Presbyterian Medical Center, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 19:305-10. 2006
    ..UFH still remains the preferred anticoagulant in the vast majority of dialysis patients requiring systemic anticoagulation and for anticoagulation of the extracorporeal hemodialysis circuit...
  22. ncbi request reprint Willingness of patients to switch from conventional to daily hemodialysis: looking before we leap
    Scott D Halpern
    Department of Medicine, University of Pennsylvania, Philadelphia, USA
    Am J Med 116:606-12. 2004
    ....
  23. pmc Dialysis versus Nondialysis in Patients with AKI: A Propensity-Matched Cohort Study
    F Perry Wilson
    Renal, Electrolyte, and Hypertension Division, Center for Clinical Epidemiology and Biostatistics, and, Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, Division of Nephrology, University of Michigan, Ann Arbor, Michigan, Penn Data Store Team, Information Services at the University of Pennsylvania, Philadelphia, Pennsylvania
    Clin J Am Soc Nephrol 9:673-81. 2014
    ..To determine which patients would benefit from initiation of dialysis for AKI, a propensity-matched cohort study was performed among a large population of patients with severe AKI...
  24. ncbi request reprint Selection and dosing of medications for management of diabetes in patients with advanced kidney disease
    James B Reilly
    Renal Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Semin Dial 23:163-8. 2010
    ..This article reviews the clinical use of insulin and other antidiabetic therapies, focusing on pharmacokinetic properties and dosing in patients with advanced kidney disease...
  25. ncbi request reprint Impact of tip culture on the management of infected tunneled hemodialysis catheters
    Emily T Cooper
    Department of Radiology, Division of Interventional Radiology, University of Pennsylvania Medical Center, 1 Silverstein, 3400 Spruce Street, Philadelphia, Pennsylvania 19104, USA
    J Vasc Interv Radiol 18:1227-31. 2007
    ..This study was conducted to determine the effect of hemodialysis catheter tip cultures (CTCs) on patient management...
  26. doi request reprint Onco-nephrology: tumor lysis syndrome
    F Perry Wilson
    Perelman School of Medicine at the University of Pennsylvania, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 7:1730-9. 2012
    ..Prevention and treatment depend on prompt recognition of patients at risk, volume repletion, allopurinol, rasburicase (a novel recombinant urate oxidase), and, when indicated, dialysis...
  27. pmc Vancomycin levels are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
    F Perry Wilson
    University of Pennsylvania Health System, Department of Medicine, Philadelphia, PA, USA
    Clin Nephrol 77:329-31. 2012
    ..Herein we present data demonstrating frequent subtherapeutic levels of vancomycin in a population of patients on CRRT. Nephrology trainees should be educated as to the risks of under-dosing antibiotics in this population...
  28. doi request reprint Viral nephropathies: core curriculum 2008
    Jeffrey S Berns
    University of Pennsylvania School of Medicine, Renal, Electrolyte and Hypertension Division, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA
    Am J Kidney Dis 52:370-81. 2008
  29. ncbi request reprint Predictors of amputation and survival following lower extremity revascularization in hemodialysis patients
    Bernard G Jaar
    Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA
    Kidney Int 65:613-20. 2004
    ..We studied the prognosis of ESRD patients undergoing their first revascularization procedure...
  30. ncbi request reprint Use of antiepileptic drugs in patients with kidney disease
    Rubeen K Israni
    Renal Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 19:408-16. 2006
    ..Monitoring of drug levels when available, careful clinical assessment of patients taking AEDs, and close collaboration with neurologists is essential to the management of patients taking AEDs...
  31. ncbi request reprint Single-center experience with the Arrow-Trerotola Percutaneous Thrombectomy Device in the management of thrombosed native dialysis fistulas
    Josh B Shatsky
    Department of Radiology, Division of Interventional Radiology, University of Pennsylvania Medical Center, 1 Silverstein, 3400 Spruce Street, Philadelphia, Pennsylvania 19104, USA
    J Vasc Interv Radiol 16:1605-11. 2005
    ....
  32. ncbi request reprint Quinine--a tonic too bitter for hemodialysis-associated muscle cramps?
    Sidney M Kobrin
    Renal Electrolyte and Hypertension Division, Department of Medicine, University of Pennsylvania School of Medicine and Hospital of University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 20:396-401. 2007
    ..We review the causes and consequences of hemodialysis-associated cramps, and discuss possible preventive measures and treatments...
  33. ncbi request reprint When chronic kidney disease becomes advanced. Guidelines for care in the emergency department and hospital
    Ari Mosenkis
    Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, USA
    Postgrad Med 119:83-91, 104. 2006
    ....
  34. doi request reprint The renal manifestations of thyroid disease
    Laura H Mariani
    University of Pennsylvania School of Medicine, Renal, Electrolyte and Hypertension Division, Presbyterian Medical Center, 39th and Market Streets, MOB 240, Philadelphia, PA 19104, USA
    J Am Soc Nephrol 23:22-6. 2012
    ..Disorders of thyroid function have also been linked to development of immune-mediated glomerular injury, and alterations in thyroid hormones and thyroid hormone testing occur in patients with kidney disease...
  35. ncbi request reprint Use of insulin and oral hypoglycemic medications in patients with diabetes mellitus and advanced kidney disease
    Richard W Snyder
    Department of Medicine, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 17:365-70. 2004
    ..In this article we will review the use of insulin and the various classes of oral medications used to treat type 2 diabetes mellitus, focusing on their pharmacokinetic properties and dosing in patients with advanced kidney disease...
  36. pmc Recruitment of live donors by candidates for kidney transplantation
    PETER P REESE
    Renal Division, University of Pennsylvania School of Medicine, 1 Founders, 3400 Spruce Street, Philadelphia, PA 19104, USA
    Clin J Am Soc Nephrol 3:1152-9. 2008
    ..It was hypothesized that preference for live donor kidney transplantation and greater knowledge about live donor transplantation are associated with candidates' initiating conversations about donation with potential donors...
  37. ncbi request reprint Willingness of dialysis patients to participate in a randomized controlled trial of daily dialysis
    Ajay K Israni
    Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA
    Kidney Int 65:990-8. 2004
    ..However, there is concern that difficulties recruiting patients may prevent the successful completion of such trials if patients believe the inconveniences of daily dialysis outweigh any potential health benefits...
  38. pmc Tumor lysis syndrome: new challenges and recent advances
    F Perry Wilson
    Perelman School of Medicine at the University of Pennsylvania, Hospital of the University of Pennsylvania, Philadelphia, PA
    Adv Chronic Kidney Dis 21:18-26. 2014
    ..Herein, we discuss the pathophysiology, epidemiology, and treatment of TLS with an emphasis on the kidney manifestations of the disease. ..
  39. ncbi request reprint What is the nephrologist's role as a primary care provider? We all have different answers
    Jeffrey S Berns
    Department of Medicine, Renal Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Clin J Am Soc Nephrol 2:601-3. 2007
  40. doi request reprint Extracorporeal treatment of cast nephropathy
    Bhavna Gakhar
    Renal Electrolyte and Hypertension Division, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
    Semin Dial 24:9-11. 2011
    ..Further research is necessary to establish the specific efficacy of each of these extracorporeal methods in the treatment of cast nephropathy...
  41. ncbi request reprint Complications of percutaneous treatment of thrombosed hemodialysis access grafts
    Francis L Weng
    University of Pennsylvania School of Medicine, Renal, Electrolyte, and Hypertension Division, University of Pennsylvania Medical Center, Philadelphia, Pennsylvania 19104, USA
    Semin Dial 16:257-62. 2003
    ..This article reviews the epidemiology, clinical significance, and management of these complications...
  42. ncbi request reprint Clinical evaluation of heme iron polypeptide: sustaining a response to rHuEPO in hemodialysis patients
    Allen R Nissenson
    University of California, Los Angeles, CA, USA
    Am J Kidney Dis 42:325-30. 2003
    ....
  43. ncbi request reprint Hemoglobin cycling in hemodialysis patients treated with recombinant human erythropoietin
    Steven Fishbane
    Winthrop University Hospital, Mineola, New York, USA
    Kidney Int 68:1337-43. 2005
    ..Therapy, however, is often observed to be associated with recurrent cyclic fluctuations in hemoglobin levels. The purpose of this analysis was to describe the phenomenology of hemoglobin cycling during rHuEPO treatment...
  44. ncbi request reprint How can erythropoietin requirements be reduced in dialysis patients?
    Peter Kotanko
    Renal Research Institute, New York, New York 10128, USA
    Semin Dial 19:363-72. 2006
  45. ncbi request reprint How should chronic medical therapies be altered with the onset of end-stage renal disease and initiation of dialysis?
    Kathleen L Wyne
    Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas 75390 8857, USA
    Semin Dial 19:8-24. 2006
  46. ncbi request reprint Evidence and implications of haemoglobin cycling in anaemia management
    Steven Fishbane
    Nephrol Dial Transplant 22:2129-32. 2007
  47. ncbi request reprint Should all patients with chronic kidney disease receive an EPO-type drug?
    Jeffrey S Berns
    Cleve Clin J Med 73:298-300. 2006
  48. doi request reprint Niacin and related compounds for treating hyperphosphatemia in dialysis patients
    Jeffrey S Berns
    Semin Dial 21:203-5. 2008
    ....
  49. ncbi request reprint Boning up on lanthanum
    Jeffrey S Berns
    Semin Dial 19:87-9. 2006
  50. ncbi request reprint Is intravenous iron safe in patients with liver disease?
    Jeffrey S Berns
    Semin Dial 15:212-3. 2002
  51. ncbi request reprint Variants in the Wilms' tumor gene are associated with focal segmental glomerulosclerosis in the African American population
    Mohammed S Orloff
    Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio 44106 7281, USA
    Physiol Genomics 21:212-21. 2005
    ..Furthermore, HIV-1 infection status interacts with genetic variations in both genes to influence this phenotype. We speculate that nephropathy liability alleles in WT1 pathway genes cause podocyte dysfunction and glomerular scarring...
  52. ncbi request reprint Frequency of sit-down patient care rounds, attainment of clinical performance targets, hospitalization, and mortality in hemodialysis patients
    Jeffrey S Berns
    Semin Dial 18:258-60. 2005
  53. ncbi request reprint Are inflammatory cytokines the "evil humors" that increase morbidity and cardiovascular mortality in chronic kidney disease?
    Jonathan S Maltzman
    Semin Dial 18:441-3. 2005